Insider Trading February 25, 2026

Innovex CEO Sells $536,854 Worth of Stock as Company Sees Mixed Quarter and Large Share Offering

Adam Anderson executed a planned sale under a Rule 10b5-1 program while Innovex reports revenue beat and an EPS miss amid a large secondary from Amberjack affiliates

By Sofia Navarro INVX
Innovex CEO Sells $536,854 Worth of Stock as Company Sees Mixed Quarter and Large Share Offering
INVX

Innovex International (NASDAQ: INVX) Chief Executive Officer Adam Anderson sold 18,837 shares on February 24, 2026, for $28.50 per share, netting about $536,854. The transaction, carried out under a Rule 10b5-1 plan established March 14, 2025, leaves Anderson with 466,744 directly held shares. The stock trades near its 52-week high and has risen sharply over six months, while the company reported mixed fourth-quarter results and disclosed a planned sale of 5.75 million shares by affiliates of Amberjack Capital Partners in a separate underwritten offering.

Key Points

  • CEO Adam Anderson sold 18,837 shares on February 24, 2026 at $28.50 per share under a Rule 10b5-1 plan; he now directly holds 466,744 shares.
  • Innovex reported mixed fourth-quarter results: adjusted EPS of $0.20 (below the $0.29 consensus) while revenue of $273.6 million beat estimates and rose 9% year-over-year and 14% sequentially.
  • Affiliates of Amberjack Capital Partners plan to sell 5,750,000 shares in an underwritten offering, with a 30-day underwriter option for up to 862,500 additional shares; Innovex will not sell shares or receive proceeds.

Insider sale details

Innovex International (NASDAQ: INVX) Chief Executive Officer Adam Anderson sold 18,837 shares of common stock on February 24, 2026, at a price of $28.50 per share. The transaction totaled approximately $536,854 and was reported on a Form 4 filed with the Securities and Exchange Commission. According to the filing, the disposition was made pursuant to a pre-arranged Rule 10b5-1 trading plan that Anderson adopted on March 14, 2025.

Post-transaction ownership and market context

Following the sale, Anderson directly owns 466,744 shares of Innovex International. The trade occurred while the stock was trading close to its 52-week high of $29.48; at the time of the report shares were quoted at $29.25.

Momentum and valuation signals

Data from InvestingPro cited in the filing shows INVX has delivered a 75% return over the past six months. InvestingPro also indicates that, on its Fair Value analysis, INVX currently appears overvalued. The company is noted as one of more than 1,400 U.S. equities covered by InvestingPro's Pro Research Reports, which provide in-depth analytical coverage.

Recent financial performance

Innovex's fourth-quarter results released recently were mixed. The company posted adjusted earnings per share of $0.20, below the analyst consensus of $0.29. Revenues, however, exceeded expectations: Innovex reported $273.6 million in revenue against an estimate of $239.47 million. The reported revenue represents a 9% increase from the same quarter a year earlier and a 14% increase from the preceding quarter.

Planned secondary offering by selling stockholders

Separately, certain affiliates of Amberjack Capital Partners, L.P. announced plans to sell 5,750,000 shares of Innovex common stock in an underwritten public offering. The selling stockholders have also indicated they expect to grant the underwriters a 30-day option to purchase up to an additional 862,500 shares. Innovex has stated it will not sell any shares as part of that offering and will not receive proceeds from the sale.

Developments in context

Taken together, the insider sale executed under a pre-set trading plan, the company's mixed quarterly metrics, third-party valuation signals from InvestingPro, and the planned share disposition by Amberjack affiliates form a cluster of recent developments affecting Innovex International. The filing and earnings details provide a clear record of these activities, while the offering by existing shareholders is structured so that Innovex itself will not directly benefit financially from the transactions.


Note on reporting

The facts in this report are drawn from the company's regulatory filings and the financial results disclosed by Innovex International as reported in the referenced filings and data services.

Risks

  • Valuation risk: InvestingPro's Fair Value analysis indicates INVX may be overvalued, which could influence investor sentiment and market pricing - this primarily affects equity markets and investors in the stock.
  • Earnings shortfall: Innovex's adjusted EPS of $0.20 missed the analyst consensus of $0.29, presenting an earnings execution risk that may affect investor confidence and equity valuations.
  • Supply pressure from shareholder offering: The planned sale of 5,750,000 shares by Amberjack affiliates, plus a potential 862,500-share over-allotment, could increase supply in the market; Innovex will not receive proceeds, highlighting potential liquidity and ownership concentration considerations for the equity market.

More from Insider Trading

Arvinas Accounting Head Executes Automatic Sale of 1,108 Shares; Stock, Results and Pipeline Updates Follow Feb 25, 2026 Cheesecake Factory Director Disposes of CAKE Shares Amid Stock Rally Feb 25, 2026 Arvinas CEO Executes $58k Automatic Stock Sale to Cover RSU Taxes Feb 25, 2026 Mitsui Sumitomo Purchases $39.38M of W. R. Berkley Stock in Multi-Day Buying Feb 25, 2026 EverCommerce CEO Disposes $120,903 in Stock; Analysts Trim Ratings on EverCommerce and Weave Feb 25, 2026